May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
The Ins2Akita mouse as a model of diabetic retinopathy
Author Affiliations & Notes
  • A.J. Barber
    Department of Ophthalmology,
    Penn State College of Medicine, Hershey, PA
  • D.A. Antonetti
    Department of Cellular and Molecular Physiology,
    Penn State College of Medicine, Hershey, PA
  • C.E. N. Reiter
    Department of Cellular and Molecular Physiology,
    Penn State College of Medicine, Hershey, PA
  • C.A. Stiller
    Department of Ophthalmology,
    Penn State College of Medicine, Hershey, PA
  • T.W. Gardner
    Department of Ophthalmology,
    Penn State College of Medicine, Hershey, PA
  • S.K. Bronson
    Department of Cellular and Molecular Physiology,
    Penn State College of Medicine, Hershey, PA
  • Footnotes
    Commercial Relationships  A.J. Barber, None; D.A. Antonetti, None; C.E.N. Reiter, None; C.A. Stiller, None; T.W. Gardner, None; S.K. Bronson, None.
  • Footnotes
    Support  JDRF, NIH, PA Lions
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3245. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.J. Barber, D.A. Antonetti, C.E. N. Reiter, C.A. Stiller, T.W. Gardner, S.K. Bronson; The Ins2Akita mouse as a model of diabetic retinopathy . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3245.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The aim of this study was to identify a mouse model of type I diabetes that could be used for genetic approaches to study the impact of diabetes on the retina. Ins2Akita mice are from the C57BL/6 background with a dominant mutation in the Ins2 gene, which results in a loss of beta cell function and failed insulin secretion 4–6 weeks postpartum. Methods: An Ins2Akita mouse colony was established and blood glucose levels were measured weekly to identify diabetic (+/–) and non–diabetic (+/+) mice. The mice were housed for a further 1 to 3 months before sacrifice. The retinas were analyzed for alterations in: vascular permeability to fluorescein–labeled bovine serum albumin (FITC–BSA); immunoreactivity for occludin, active caspase–3 and glial fibrillary acidic protein; and insulin receptor kinase activity. Results: The mean blood glucose of Ins2Akita diabetic and non–diabetic mice at sacrifice was 412±18.3 and 159±9.6 mg/dL, respectively, while the average body weights were 24.2±1.21 and 33.2±1.18 g, respectively. Retinal vascular permeability to FITC–BSA was significantly increased in Ins2Akita diabetic compared to non–diabetic mice (p<0.005). Occludin immunoreactivity was more punctate in large arterioles, and there were significantly more caspase–3 positive cells in Ins2Akita diabetic compared to non–diabetic mice (p<0.01). GFAP immunoreactivity was unchanged in the Ins2Akita diabetic mice but the astrocytes appeared atrophied. Ins2Akita diabetes also significantly reduced insulin receptor kinase activity by 27% of control (p<0.05). Conclusions: Consistent with the streptozotocin–diabetic rat, vascular permeability, tight junction disruption, apoptosis and glial abnormalities increase, while insulin receptor function is diminished in the diabetic Ins2Akita mouse. These data show that the Ins2Akita mouse is an excellent animal model for molecular genetic studies of diabetic retinopathy.

Keywords: diabetic retinopathy • apoptosis/cell death • cell adhesions/cell junctions 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×